/PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for oncology, today announced the formation.
Two close colleagues at New York s Memorial Sloan Kettering Cancer Center, world leaders in hematopoietic stem cell transplantation (HSCT) have published their 100th peer-reviewed paper as coauthors.
Actinium Completes Enrollment in the Pivotal Phase 3 SIERRA Trial of Iomab-B prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.